Zobrazeno 1 - 10
of 100
pro vyhledávání: '"Crucitta E"'
Autor:
Lorusso, V. *, Crucitta, E., Panza, N., Silvestris, N., Guida, M., Carpagnano, F., Mancarella, S., Sambiasi, D., De Lena, M.
Publikováno v:
In Annals of Oncology December 2002 13(12):1862-1867
Autor:
Comella, P. *, Crucitta, E., De Vita, F., De Lucia, L., Farris, A., Del Gaizo, F., Palmeri, S., Iannelli, A., Mancarella, S., Tafuto, S., Maiorino, L., Buzzi, F., De Cataldis, G.
Publikováno v:
In Annals of Oncology June 2002 13(6):866-873
Autor:
De Lena, M. *, Lorusso, V., Latorre, A., Fanizza, G., Gargano, G., Caporusso, L., Guida, M., Catino, A., Crucitta, E., Sambiasi, D., Mazzei, A.
Publikováno v:
In European Journal of Cancer February 2001 37(3):364-368
Autor:
Lorusso, V, Crucitta, E, Silvestris, N, Catino, A, Caporusso, L, Mazzei, A, Guida, M, Latorre, A, Sambiasi, D, D'Amico, C, Schittulli, F, Calabrese, P, De Lena, M
Publikováno v:
British Journal of Cancer. 2/24/2003, Vol. 88 Issue 4, p491-495. 5p.
Autor:
Stefania Munaó, Raffaele M, G. Picone, A. Valenti, Marzia Mare, Crucitta E, Giampietro Gasparini, Amadio P, Mario Mesiti, Stefano Cascinu
Publikováno v:
The International Journal of Biological Markers. 14:239-242
A number of antiangiogenic agents have been developed as pharmaceuticals and are currently being tested in clinical studies. Potential strategies to enhance the activity of angiogenesis inhibitors could be to combine them, or better still, to adminis
Autor:
Lorusso, V., Crucitta, E., Silvestris, N., Rosati, G., Manzione, L., DE LENA, M., Palmeri, S., Gebbia, V., Mancarella, S., Sobrero, A., Pezzella, G., Comella, P., Mangiameli, A., Muci, D., ITALIAN BLADDER CANCER GROUP
The purpose of the study was to evaluate the antitumor activity and the safety of paclitaxel combined with gemcitabine and cisplatin in patients affected by advanced transitional cell carcinoma of the urothelium (TCC). Eighty-five patients affected b
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::a97d1b81d4a5156cc692eb8d94e38446
http://hdl.handle.net/10447/20077
http://hdl.handle.net/10447/20077
Autor:
COMELLA P, CRUCITTA E, DE VITA, Ferdinando, DE LUCIA L, FARRIS A, DEL GAIZO F, PALMERI S, IANNELLI A, MANCARELLA S, TAFUTO S, MAIORINO L, BUZZI F, DE CATALDIS G, CASARETTI R, AVALLONE A, MONTELLA M, COMELLA G, CATALANO G, LORUSSO V, DE LENA M, BIGLIETTO M, SANNA G, SAROBBA MG, BELLI C, RUSSO A, PIZZARDI V, ACCURSO V, MUSCA A, GRAVINA A, LEOPALDI G, BRUNETTI C, MUCI D, LEO S, AVINO F, DE LUCA L, GRECO E, AIELLO C., ORDITURA, Michele
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od______3977::3d5465f657d20c66c6000b2d6b57ce60
http://hdl.handle.net/11591/191435
http://hdl.handle.net/11591/191435
Autor:
Cappuzzo, F., Novello, Silvia, DE MARINIS, F., Franciosi, V., Maur, M., Ceribelli, A., Lorusso, V., Barbieri, F., Castaldini, L., Crucitta, E., Marini, L., Bartolini, S., Crinò, GV SCAGLIOTTI AND L.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od_______970::3088bd6e1e46aa44c5e5862d46dffd91
http://hdl.handle.net/2318/78686
http://hdl.handle.net/2318/78686
Publikováno v:
Drugs of today (Barcelona, Spain : 1998). 37(9)
Letrozole is a third-generation aromatase inhibitor for use in postmenopausal women with hormonal-sensitive breast cancer. This drug was found to reduce or effectively shrink tumors in a significant number of such patients. It exhibits antitumor acti
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.